Associated Papers
Mutational Profile Enables the Identification of a High-Risk Subgroup in Myelodysplastic Syndromes with Isolated Trisomy 8.
Toribio-Castelló S et al.
Cancers, 2023
37568638 (PubMed )
Supplement: cancers-15-03822-s001.zip › Supplementary_tables.xlsx › Table_S2
Measurable residual disease of canonical versus non-canonical DNMT3A, TET2, or ASXL1 mutations in AML at stem cell transplantation.
Jentzsch M et al.
Bone Marrow Transplantation, 2021
34267355 (PubMed )
Supplement: 41409_2021_1407_MOESM1_ESM.docx
Angioimmunoblastic T-cell lymphoma contains multiple clonal T-cell populations derived from a common TET2 mutant progenitor cell.
Yao WQ et al.
The Journal of Pathology, 2020
31859368 (PubMed )
Supplement: PATH-250-346-s006.xlsx › mutation__3_
Peripheral blood cell-free DNA is an alternative tumor DNA source reflecting disease status in myelodysplastic syndromes.
Suzuki Y et al.
Cancer Science, 2016
27323954 (PubMed )
Supplement: CAS-107-1329-s003.xlsx › Sheet1
Genetic profiling in acute myeloid leukaemia--where are we and what is its role in patient management.
Ofran Y et al.
British Journal of Haematology, 2013
TET2 mutation is an unfavorable prognostic factor in acute myeloid leukemia patients with intermediate-risk cytogenetics.
Chou WC et al.
Blood, 2011
Select a paper to view details